SEC Form 4 · accession 0001209191-15-086167
MARRONE BIO INNOVATIONS INC · MBII
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard E Rominger
Director
Period of report
Dec 17, 2015
Accepted (ET)
Dec 18, 2015 · 5:38 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001441693
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F2 | — | Dec 17, 2015 | A | 17,895 | A | — | — | Common Stock | 17,895 | 17,895 | D |
Explanation of responses
- F1Each restricted stock unit represents a contingent right to receive one share of Marrone Bio Innovations, Inc. common stock.
- F2The restricted stock units vest with respect to 7/12ths of the total shares on December 17, 2015, and with respect to 1/12th the of the total shares subject to the grant monthly thereafter. Vested shares will be delivered to the reporting person upon the earlier of the reporting person's separation of service with the Company or immediately prior to a change in control event.